142 related articles for article (PubMed ID: 303886)
1. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
Pelton SI; Shurin PA; Klein JO; Finland M
Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
Kirven LA; Thornsberry C
Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
[TBL] [Abstract][Full Text] [Related]
3. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
Yogev R; Moxon ER
J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae.
Schwartz RH; Rodriguez WJ; Khan WN; Mann R; Barsanti RG; Ross S
Rev Infect Dis; 1982; 4(2):514-6. PubMed ID: 6981169
[TBL] [Abstract][Full Text] [Related]
5. In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination.
Marks MI; Kazemi M; MacKay E
Antimicrob Agents Chemother; 1973 Nov; 4(5):555-9. PubMed ID: 4791490
[TBL] [Abstract][Full Text] [Related]
6. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Haemophilus influenzae isolates from blood and cerebrospinal fluid to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.
McGowan JE; Terry PM; Nahmias AJ
Antimicrob Agents Chemother; 1976 Jan; 9(1):137-9. PubMed ID: 1083198
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
Sinai R; Hammerberg S; Marks MI; Pai CH
Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-sulfamethoxazole in the treatment of otitis media secondary to ampicillin-resistant strains of Haemophilus influenzae.
Schwartz R; Rodriguez WJ; Khan W; Mann R; Barsanti RG; Ross S
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):281-4. PubMed ID: 6778328
[TBL] [Abstract][Full Text] [Related]
10. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
Wallace RJ; Wiss K; Bushby MB; Hollowell DC
Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
[TBL] [Abstract][Full Text] [Related]
12. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.
Hammerschlag MR
Rev Infect Dis; 1982; 4(2):500-5. PubMed ID: 6981168
[TBL] [Abstract][Full Text] [Related]
13. Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.
Kirven LA; Thornsberry C
Antimicrob Agents Chemother; 1978 Nov; 14(5):731-6. PubMed ID: 310281
[TBL] [Abstract][Full Text] [Related]
14. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
Traub WH; Fukushima PI
Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
[TBL] [Abstract][Full Text] [Related]
15. Effect of TMP-SMX on nasopharyngeal carriage of ampicillin-sensitive and ampicillin-resistant hemophilus influenzae type B.
Yogev R; Lander HB; Davis AT
J Pediatr; 1978 Sep; 93(3):394-7. PubMed ID: 308533
[TBL] [Abstract][Full Text] [Related]
16. Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.
Bergeron MG; Simard P; Provencher P
J Clin Microbiol; 1987 Apr; 25(4):650-5. PubMed ID: 3494745
[TBL] [Abstract][Full Text] [Related]
17. Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 1997 Jan; 35(1):125-31. PubMed ID: 8968893
[TBL] [Abstract][Full Text] [Related]
18. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
Bismuth R; Jarlier V; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
[TBL] [Abstract][Full Text] [Related]
19. Therapy of antimicrobial-resistant typhoid fever.
Butler T; Linh NN; Arnold K; Adickman MD; Chau DM; Muoi MM
Antimicrob Agents Chemother; 1977 Apr; 11(4):645-50. PubMed ID: 324398
[TBL] [Abstract][Full Text] [Related]
20. Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol.
Marks MI; Weinmaster G
Antimicrob Agents Chemother; 1975 Dec; 8(6):657-63. PubMed ID: 1082293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
